Surprisingly, cortactin levels in B-ALL cells from patients with BM relapse were increased threefold compared to cells from newly diagnosed patients (Fig. 4a, Table 1), and this was true in all cell subsets (Fig. 4b). Here, CTTN is linked to acute lymphoblastic leukemia.